Literature DB >> 23813541

Evaluating the accuracy of electronic pediatric drug dosing rules.

Eric S Kirkendall1, S Andrew Spooner, Judith R Logan.   

Abstract

OBJECTIVE: To determine the accuracy of vendor-supplied dosing eRules for pediatric medication orders. Inaccurate or absent dosing rules can lead to high numbers of false alerts or undetected prescribing errors and may potentially compromise safety in this already vulnerable population.
MATERIALS AND METHODS: 7 months of medication orders and alerts from a large pediatric hospital were analyzed. 30 medications were selected for study across 5 age ranges and 5 dosing parameters. The resulting 750 dosing rules from a commercial system formed the study corpus and were examined for accuracy against a gold standard created from traditional clinical resources.
RESULTS: Overall accuracy of the rules in the study corpus was 55.1% when the rules were transformed to fit a priori age ranges. Over a pediatric lifetime, the dosing rules were accurate an average of 57.6% of the days. Dosing rules pertaining to the newborn age range were as accurate as other age ranges on average, but exhibited more variability. Daily frequency dosing parameters showed more accuracy than total daily dose, single dose minimum, or single dose maximum. DISCUSSION: The accuracy of a vendor-supplied set of dosing eRules is suboptimal when compared with traditional dosing sources, exposing a gap between dosing rules in commercial products and actual prescribing practices by pediatric care providers. More research on vendor-supplied eRules is warranted in order to understand the effects of these products on safe prescribing in children.

Entities:  

Keywords:  CPOE; Decision Support Systems, Clinical; Electronic Health Record; Electronic Medical Record; Medical Order Entry System; Medication Alert System

Mesh:

Substances:

Year:  2013        PMID: 23813541      PMCID: PMC3957390          DOI: 10.1136/amiajnl-2013-001793

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  25 in total

1.  Overriding of drug safety alerts in computerized physician order entry.

Authors:  Heleen van der Sijs; Jos Aarts; Arnold Vulto; Marc Berg
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

2.  Evaluating the off-label use of medications in children.

Authors:  Lea S Eiland; Patrice Knight
Journal:  Am J Health Syst Pharm       Date:  2006-06-01       Impact factor: 2.637

Review 3.  What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior?

Authors:  Angela Schedlbauer; Vibhore Prasad; Caroline Mulvaney; Shobha Phansalkar; Wendy Stanton; David W Bates; Anthony J Avery
Journal:  J Am Med Inform Assoc       Date:  2009-04-23       Impact factor: 4.497

4.  In-label and off-label use of respiratory drugs in the Italian paediatric population.

Authors:  P Baiardi; A Ceci; M Felisi; L Cantarutti; S Girotto; M Sturkenboom; E Baraldi
Journal:  Acta Paediatr       Date:  2010-01-27       Impact factor: 2.299

5.  Turning off frequently overridden drug alerts: limited opportunities for doing it safely.

Authors:  Heleen van der Sijs; Jos Aarts; Teun van Gelder; Marc Berg; Arnold Vulto
Journal:  J Am Med Inform Assoc       Date:  2008-04-24       Impact factor: 4.497

6.  The impact of computerized physician order entry on medication error prevention.

Authors:  D W Bates; J M Teich; J Lee; D Seger; G J Kuperman; N Ma'Luf; D Boyle; L Leape
Journal:  J Am Med Inform Assoc       Date:  1999 Jul-Aug       Impact factor: 4.497

7.  Medication errors in paediatric outpatients.

Authors:  Rainu Kaushal; Donald A Goldmann; Carol A Keohane; Erika L Abramson; Seth Woolf; Catherine Yoon; Katherine Zigmont; David W Bates
Journal:  Qual Saf Health Care       Date:  2010-08-10

8.  Adverse drug events in pediatric outpatients.

Authors:  Rainu Kaushal; Donald A Goldmann; Carol A Keohane; Melissa Christino; Melissa Honour; Andrea S Hale; Katherine Zigmont; Lisa Soleymani Lehmann; James Perrin; David W Bates
Journal:  Ambul Pediatr       Date:  2007 Sep-Oct

9.  Risk factors in preventable adverse drug events in pediatric outpatients.

Authors:  Stephanie O Zandieh; Donald A Goldmann; Carol A Keohane; Catherine Yoon; David W Bates; Rainu Kaushal
Journal:  J Pediatr       Date:  2007-11-19       Impact factor: 4.406

10.  Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.

Authors:  Praveen Kumar; Jennifer K Walker; Kristin M Hurt; Kimberly M Bennett; Neal Grosshans; Michael A Fotis
Journal:  J Pediatr       Date:  2007-10-22       Impact factor: 4.406

View more
  4 in total

1.  Sensitivity and specificity of dosing alerts for dosing errors among hospitalized pediatric patients.

Authors:  Jeremy S Stultz; Kyle Porter; Milap C Nahata
Journal:  J Am Med Inform Assoc       Date:  2014-02-04       Impact factor: 4.497

2.  Analysis of electronic medication orders with large overdoses: opportunities for mitigating dosing errors.

Authors:  E S Kirkendall; M Kouril; T Minich; S A Spooner
Journal:  Appl Clin Inform       Date:  2014-01-08       Impact factor: 2.342

3.  Meaningful Use of Electronic Health Records: Experiences From the Field and Future Opportunities.

Authors:  Sarah Patricia Slight; Eta S Berner; William Galanter; Stanley Huff; Bruce L Lambert; Carole Lannon; Christoph U Lehmann; Brian J McCourt; Michael McNamara; Nir Menachemi; Thomas H Payne; S Andrew Spooner; Gordon D Schiff; Tracy Y Wang; Ayse Akincigil; Stephen Crystal; Stephen P Fortmann; David W Bates
Journal:  JMIR Med Inform       Date:  2015-09-18

4.  Automated identification of antibiotic overdoses and adverse drug events via analysis of prescribing alerts and medication administration records.

Authors:  Eric S Kirkendall; Michal Kouril; Judith W Dexheimer; Joshua D Courter; Philip Hagedorn; Rhonda Szczesniak; Dan Li; Rahul Damania; Thomas Minich; S Andrew Spooner
Journal:  J Am Med Inform Assoc       Date:  2017-03-01       Impact factor: 4.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.